Commentary
Ideas and insights on pressing issues facing the business world.

By Oded Netzer, Christopher Frank and Paul MagnoneJuly 13, 2026
Latest stories from Fortune
More CommentaryPage 12 of 100

By David SprengMarch 20, 2026

By David PlacekMarch 20, 2026

By Fabio BinMarch 20, 2026

By Anthony ScaramucciMarch 19, 2026

By Ram CharanMarch 19, 2026

By Mick MulvaneyMarch 19, 2026

The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
By Annette Bakker and Andrew W. LoMarch 19, 2026

By Keith Ferrazzi, Wendy Smith and Dan RobertsMarch 19, 2026

By Dennis KozakMarch 19, 2026

By Paul PoseyMarch 18, 2026

By Guillaume LongMarch 18, 2026

By Katica RoyMarch 18, 2026

By Jack SchlossbergMarch 18, 2026

By Jeffrey Sonnenfeld and Steven TianMarch 17, 2026

By Kate WingetMarch 17, 2026

By David K. YoungMarch 17, 2026

By Jeff BurninghamMarch 17, 2026

By Josh MaceyMarch 17, 2026

By Nnenna LynchMarch 17, 2026

By Wendi SafstromMarch 17, 2026

By Stijn Van Nieuwerburgh and Wayne YuMarch 16, 2026

By Christine O'Brien and Lex SuvantoMarch 16, 2026

By Debbie WeinsteinMarch 16, 2026

By Barrett BingleyMarch 15, 2026

By Alex ChepovoiMarch 15, 2026

By Vivek RanadiveMarch 14, 2026
Most Popular






















